关于印度议会2017-2024年立法者提出的药物相关问题的问题
Preethi J Shenoy1, Rajeshwari Shastry1, Ashwin Kamath2
1Department of Pharmacology, Kasturba Medical College Mangalore, Manipal Academy of Higher Education, Manipal, India.
BMC public health
|September 24, 2025
概括
印度国会议员积极质疑卫生部关于药物,包括仿制药和定价,从2017-2024. 这种议会监督反映了对不断变化的公共卫生需求和药物供应挑战的响应能力.
科学领域:
- 公共卫生 公共卫生
- 卫生政策 卫生政策
- 议会监督 议会监督
背景情况:
- 议会问题对于监测公共卫生问题至关重要.
- 这项研究检查了印度议会成员 (MP) 对卫生和家庭福利部 (2017年1月至2024年2月) 提出的与药物相关的查询.
- 重点领域包括仿制药和药品定价.
研究的目的:
- 分析印度国会议员提出的与药物有关的问题的范围和主题.
- 了解立法参与的毒品政策和医疗保健服务.
主要方法:
- 从议会数字存储库中提取了与健康有关的问题.
- 使用关键字搜索 (R统计软件) 和手动确认识别了与药物相关的问题.
- 总结并将问题分类为主题,并指出药物,疾病和人口统计数据.
主要成果:
- 确定了1121个与药物相关的问题,占所有健康查询的19.42%.
- 主要主题包括癌症治疗,药物监管,传染病和卫生基础设施.
- COVID-19,抗微生物药物和癌症化疗是突出的话题,在COVID后的关注度增加.
结论:
- 立法者积极与卫生部就药物需求进行接触,表明对公共卫生趋势的反应能力.
- 该研究强调了议会对话在应对医疗保健挑战和影响政策方面的作用.
- 未来的研究应该探索特定的药物类别和健康问题,以进一步了解立法影响.
相关概念视频
Issues And Trends In Healthcare Delivery System
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Drug Regulation
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
Pharmacovigilance
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Prescription, Nonprescription and Orphan Drugs
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
Drug Control Governance: Regulatory Bodies and Their Impact
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with a...
Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...


